Pharmabiz
 

OGT releases application note to support researchers dealing with NGS data analysis

Oxford, UKSaturday, August 4, 2012, 16:00 Hrs  [IST]

Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has released a new application note, ‘focusing on results not data — comprehensive data analysis for targeted next generation sequencing (NGS)’, to support researchers in dealing with the challenges of complex NGS data analysis. The application note discusses OGT’s next generation sequencing (NGS) data analysis pipeline, which incorporates complete sequence data processing, including the annotation, filtering and ranking of single nucleotide polymorphisms (SNPs), as well as insertions and deletions (indels). This approach allows researchers to focus on their results rather than the complexities of analysis, specifically the high-quality, relevant, filtered and ranked variant information.

The pipeline is ideal for biomedical and translational researchers, who do not have ready access to bioinformatics expertise, and is designed to make it easy to understand the results obtained from targeted sequencing and whole exome studies so that researchers can focus on their biological significance. To discover the full depth of OGT’s data analysis pipeline download the application note, or visit OGT’s website for more details about the company’s Genefficiency. targeted sequencing services.

To coincide with the release of the new application note, OGT is offering free data analysis for targeted sequencing service quotes requested before the 10th of August 2012, including whole exome or custom panel sequencing (terms and conditions apply).

OGT’s Genefficiency is a unique combination of world-leading platforms, people, processing power and performance synchronised to deliver rapid, high-quality genomic data to customers worldwide. OGT’s CytoSure™ cytogenetics array, labelling and interpretation software products and services provide a complete solution for the detection of chromosomal abnormalities. Together, Genefficiency and CytoSure offer a unique, standardised and integrated solution for cytogenetics research.

 
[Close]